Bone morphogenetic protein but not transforming growth factor-β enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer

Journal of Bone and Joint Surgery

Volumn 81, Issue 12, 1999, Pages 1717-1729

  Heckman, James D ^a,c   Ehler, William ^b   Brooks, Bryan P ^c   Aufdemorte, Thomas B ^c   Lohmann, Christoph H ^c   Morgan, Thane ^c   Boyan, Barbara D ^c  

^a Audie L Murphy Memorial Veterans Administration Center   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; POLYGLACTIN; POLYLACTIC ACID; POLYMER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; DIAPHYSIS DYSPLASIA; DOG; FRACTURE HEALING; IMPLANT; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERIOSTEUM; PRIORITY JOURNAL;

EID: 0032741552     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199912000-00009     Document Type: Article

References (60)

1. Agrawal, C. M.; Best, J.; Heckman, J. D.; and Boyan, B. D.: Protein release kinetics of a biodegradable implant for fracture non-unions. Biomaterials, 16: 1255-1260, 1995.
2. Agrawal, C. M.; Boyan, B. D.; and Heckman, J. D.: Biodegradable implant for fracture nonunions. United States patent number 5,492,697, issued in 1995.
3. Athanasiou, K. A.; Niederauer, G. G.; and Agrawal, C. M.: Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials, 17: 93-102, 1996.
4. Beck, L. S.; Amento, E. P.; Xu, Y.; Degsuzman, L.; Lee, W. P.; Nguyen, T.; and Gillett, N. A.: TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1. J. Bone and Min. Res., 8: 753-761, 1993.
5. Boden, S. D.; Schimandle, J. H.; and Hutton, W. C.: Lumbar intertransverse-process spinal arthrodesis with use of a bovine bone-derived osteoinductive protein. A preliminary report. J. Bone and Joint Surg., 77-A: 1404-1417, Sept. 1995.
6. Boden, S. D.; Schimandle, J. H.; Hutton, W. C.; Damien, C. J.; Benedict, J. J.; Baranowski, C.; and Collier, S.: In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion. J. Spinal Dis., 10: 1-11, 1997.
7. Bonewald, L. F., and Munday, G. R.: Role of transforming growth factor-beta in bone remodeling. Clin. Orthop., 250: 261-276, 1990.
8. Bos, R. R. M.; Rozema, F. R.; Boering, G.; Nijenhuis, A. J.; and Pennings, A. J.: Bio-absorbable plates and screws for internal fixation of mandibular fractures. A study in six dogs. Internat. J. Oral and Maxillofac. Surg., 18: 365-369, 1989.
9. Boyan, B. D.; Schwartz, Z.; Swain, L. D.; Khare, A. G.; Heckman, J. D.; Ramirez, V.; Peters, P.; and Carnes, D. L., Jr.: Initial effects of partially purified bone morphogenetic protein on the expression of glycosaminoglycan, collagen, and alkaline phosphatase in nonunion cell cultures. Clin. Orthop., 278: 286-304, 1992.
10. Boyan, B. D.; Sylvia, V. L.; Piorkowski, G.; Kieswetter, K.; Liu, Y.; Wozney, J.; Harris, S. E.; Dean, D. D.; and Schwartz, Z.: BMP-2 and TGF-β induce chondrocytes in the endochondral pathway to become 1,25-(OH)2D3-responsive [abstract]. J. Bone and Min. Res., 12 (Supplement 1): S308, 1997.
11. Boyan, B. D.; Caplan, A. I.; Heckman, J. D.; Lennon, D. P.; Ehler, W.; and Schwartz, Z.: Osteochondral progenitor cells in acute and chronic canine nonunions. J. Orthop. Res., 17: 246-255, 1999.
12. Boyne, P. J.: Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone, 19 (Supplement 1): 83S-92S, 1996.
13. Burwell, R. G.: The function of bone marrow in the incorporation of a bone graft. Clin. Orthop., 200: 125-141, 1985.
14. Canalis, E.; Centrella, M.; and Urist, M. R.: Effect of partially purified bone morphogenetic protein on DNA synthesis and cell replication in calvarial and fibroblast cultures. Clin. Orthop., 198: 289-296, 1985.
15. Caplan, A. I., and Boyan, B. D.: Endochondral bone formation: the lineage cascade. In Bone 8: Mechanisms of Bone Development and Growth, pp. 1-46. Edited by B. K. Hall. Boca Raton, CRC Press, 1994.
16. Centrella, M.; McCarthy, T. L.; and Canalis, E.: Skeletal tissue and transforming growth factor beta. FASEB J., 2: 3066-3073, 1988.
17. Chapman, M. W.; Bucholz, R.; and Cornell, C.: Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J. Bone and Joint Surg., 79-A: 495-502, April 1997.
18. Committee on Care and Use of Laboratory Animals of the Institute for Laboratory Animal Resources, Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Publication 86-23, revised 1985. Washington, D.C., United States Department of Health and Human Resources, Public Health Service, National Institutes of Health, 1986.
19. Coombs, A. G. A.; Heckman, J. D.; and Boyan, B. D.: Unpublished data, 1995.
20. Cornell, C. N., and Lane, J. M.: Newest factors in fracture healing. Clin. Orthop., 211: 297-311, 1992.
21. Craig, P. H.; Williams, J. A.; Davis, K. W.; Magoun, A. D.; Levy, A. J.; Bogdansky, S.; and Jones, J. P., Jr.: A biologic comparison of polyglactin 910 and polyglycolic acid synthetic absorbable sutures. Surg., Gynec. and Obstet., 141: 1-10, 1975.
22. Cutright, D. E., and Hunsuck, E. E.: Tissue reaction to the biodegradable polylactic acid suture. Oral Surg., Oral Med., and Oral Pathol., 31: 134-139, 1971.
23. dos Santos Neto, F. L., and Volpon, J. B.: Experimental nonunion in dogs. Clin. Orthop., 187: 260-271, 1984.
24. Drivdahl, R. H.; Howard, G. A.; and Baylink, D. J.: Extracts of bone contain a potent regulator of bone formation. Biochim. Biophys. Acta, 714: 26-33, 1982.
25. Glowacki, J.; Kaban, L. B.; Murray, J. E.; Folkman, J.; and Mulliken, J. B.: Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet, 1: 959-962, 1981.
26. Glowacki, J.; Kaban, L. B.; Murray, J. E.; Folkman, J.; and Mulliken, J. B.: Bone implants and induced osteogenesis [letter]. Lancet, 1: 452, 1982.
27. Heckman, J. D.; Boyan, B. D.; Aufdemorte, T. B.; and Abbott, J. T.: The use of bone morphogenetic protein in the treatment of non-union in a canine model. J. Bone and Joint Surg., 73-A: 750-764, June 1991.
28. Heckman, J. D.; Aufdemorte, T. B.; Athanasiou, K. A.; Schwartz, Z.; Korvick, D. L.; Brooks, B. P.; Nguyen, T.; Wong, R.; Orgpipattanakul, B.; and Boyan, B. D.: Treatment of acute osteotomy defects in the dog radius with rhTGF-β1. Trans. Orthop. Res. Soc., 20: 590, 1995.
29. Hollinger, J.; Mark, D. E.; Bach, D. E.; Reddi, A. H.; and Seyfer, A. E.: Calvarial bone regeneration using osteogenin. J. Oral and Maxillofac. Surg., 47: 1182-1187, 1989.
30. Johnson, E. E.; Urist, M. R.; and Finerman, G. A. M.: Bone morphogenetic protein augmentation grafting of resistant femoral non-unions. A preliminary report. Clin. Orthop., 230: 257-265, 1988.
31. Joyce, M. E.; Jingushi, S.; and Bolander, M. E.: Transforming growth factor-beta in the regulation of fracture repair. Orthop. Clin. North America, 21: 199-209, 1990.
32. Joyce, M. E.; Roberts, A. B.; Sporn, M. B.; and Bolander, M. E.: Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol., 110: 2195-2207, 1990.
33. Kaban, L. B., and Glowacki, J.: Augmentation of rat mandibular ridge with demineralized bone implants. J. Dental Res., 63: 998-1002, 1984.
34. Kieswetter, K.; Schwartz, Z.; Niederauer, M. O.; Leatherbury, N. C.; Korvick, D.; Xiong, L.; Wirth, M.; Diaz, J. L.; Niederauer, G. G.; and Boyan, B. D.: Segmental defect repair with biodegradable tissue scaffolds. Trans. Orthop. Res. Soc., 22: 900, 1997.
35. Lane, J. M., and Sandhu, H. S.: Current approaches to experimental bone grafting. Orthop. Clin. North America, 18: 213-225, 1987.
36. Maxwell, S. E., and Delaney, H. D.: Designing Experiments and Analyzing Data: A Model Comparison Perspective. Pacific Grove, California, Brooks/Cole Publishing, 1990.
37. Miller, E. J., and Martin, G. R.: The collagen of bone. Clin. Orthop., 59: 195-232, 1968.
38. Miller, R. A.; Brady, J. M.; and Cutright, D. E.: Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res., 11: 711-719, 1977.
39. Müller, J.; Schenk, R.; and Willenegger, H.: Experimentelle Untersuchungen uber die Entstehung reaktiver Pseudarthrosen am Hunderadius. Helvetica Chir. Acta, 35: 301-308, 1968.
40. Nilsson, O. S.; Urist, M. R.; Dawson, E. G.; Schmalzried, T. P.; and Finerman, G. A. M.: Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. J. Bone and Joint Surg., 68-B(4): 635-642, 1986.
41. Noda, M., and Camilliere, J. J.: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology, 124: 2991-2994, 1989.
42. Rosen, D. M.; Stempien, S. A.; Thompson, A. Y.; and Seyedin, S. M.: Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro. J. Cell. Physiol., 134: 337-346, 1988.
43. Rosen, D. M.; Nathan, R.; Armstrong, R.; Bentz, H.; Thompson, A.; DeLeon, E.; Buckman, E.; Fiedler, L.; and Seyedin, S.: Bone induction and transforming growth factor-beta. Ann. New York Acad. Sci., 593: 98-106, 1990.
44. Sampath, T. K.; DeSimone, D. P.; and Reddi, A. H.: Extracellular bone matrix-derived growth factor. Exper. Cell Res., 142: 460-464, 1982.
45. Sampath, T. K.; Nathanson, M. A.; and Reddi, A. H.: In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc. Nat. Acad. Sci., 81: 3419-3423, 1984.
46. Sampath, T. K.; Muthukumaran, N.; and Reddi, A. H.: Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc. Nat. Acad. Sci., 84: 7109-7113, 1987.
47. Sato, K., and Urist, M. R.: Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin. Orthop., 197: 301-311, 1985.
48. Schwartz, Z.; Bonewald, L. F.; Caulfield, K.; Brooks, B.; and Boyan, B. D.: Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. Endocrinology, 132: 1544-1552, 1993.
49. Seyedin, S. M.; Thompson, A. Y.; Bentz, H.; Rosen, D. M.; McPherson, J. M.; Conti, A.; Siegel, N. R.; Galluppi, G. R.; and Piez, K. A.: Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J. Biol. Chem., 261: 5693-5695, 1986.
50. Shapiro, S. S., and Wilk, M. B.: An analysis of variance test for normality (complete samples). Biometrika, 52: 591-611, 1965.
51. Stevenson, S.; Cunningham, N.; Toth, J.; Davy, D.; and Reddi, A. H.: The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. J. Bone and Joint Surg., 76-A: 1676-1687, Nov. 1994.
52. Takagi, K., and Urist, M. R.: The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann. Surg., 196: 100-109, 1982.
53. Tuli, S. M.: Bridging of bone defects by massive bone grafts in tumorous conditions and in osteomyelitis. Clin. Orthop., 87: 60-73, 1972.
54. Urist, M. R.; Terashima, Y.; Nakagawa, M.; and Stamos, C.: Cartilage tissue differentiation from mesenchymal cells derived from mature muscle in tissue culture. In Vitro, 14: 697-706, 1978.
55. Urist, M. R.; Lietze, A.; Mizutani, H.; Takagi, K., Triffitt, J. T.; Amstutz, J.; DeLange, R.; Termine, J.; and Finerman, G. A. M.: A bovine low molecular weight bone morphogenetic protein (BMP) fraction, Clin. Orthop., 162: 219-232, 1982.
56. Urist, M. R.; Huo, Y. K.; Brownell, A. G.; Hohl, W. M.; Buyske, J.; Lietze, A.; Tempst, P.; Hunkapiller, M.; and DeLange, R. J.: Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc. Nat. Acad. Sci., 81: 371-375, 1984.
57. Werntz, J.; Lane, J.; Piez, K.; Seyedin, S.; Burstein, A.; and Gebhardt, M.: The repair of segmental bone defects with collagen and marrow. Orthop. Trans., 10: 262-263, 1986.
58. Winet, H., and Hollinger, J. O.: Incorporation of polylactide-polyglycolide in a cortical defect: neoosteogenesis in a bone chamber. J. Biomed. Mater. Res., 27: 667-676, 1993.
59. Zegzula, H. D.; Buck, D. C.; Brekke, J.; Wozney, J. M.; and Hollinger, J. O.: Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone and Joint Surg., 79-A: 1778-1790, Dec. 1997.
60. Zellin, G., and Linde, A.: Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. An experimental study in rabbits. Scandinavian J. Plast. and Reconstr. Surg. and Hand Surg., 31: 97-104, 1997.